Balancing repair and tolerance of DNA damage caused by alkylating agents
- PMID: 22237395
- PMCID: PMC3586545
- DOI: 10.1038/nrc3185
Balancing repair and tolerance of DNA damage caused by alkylating agents
Abstract
Alkylating agents constitute a major class of frontline chemotherapeutic drugs that inflict cytotoxic DNA damage as their main mode of action, in addition to collateral mutagenic damage. Numerous cellular pathways, including direct DNA damage reversal, base excision repair (BER) and mismatch repair (MMR), respond to alkylation damage to defend against alkylation-induced cell death or mutation. However, maintaining a proper balance of activity both within and between these pathways is crucial for a favourable response of an organism to alkylating agents. Furthermore, the response of an individual to alkylating agents can vary considerably from tissue to tissue and from person to person, pointing to genetic and epigenetic mechanisms that modulate alkylating agent toxicity.
Figures
References
-
- Ballschmiter K. Pattern and sources of naturally produced organohalogens in the marine environment: biogenic formation of organohalogens. Chemosphere. 2003;52:313–24. - PubMed
-
- Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 1999;424:127–42. - PubMed
-
- Hamilton JT, McRoberts WC, Keppler F, Kalin RM, Harper DB. Chloride methylation by plant pectin: an efficient environmentally significant process. Science. 2003;301:206–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
